10x Genomics Inc (NAS:TXG)
$ 52.15 +6.43 (+14.1%) Market Cap: 6.62 Bil Enterprise Value: 6.15 Bil PE Ratio: 0 PB Ratio: 8.21 GF Score: 61/100

Q1 2026 10X Genomics Inc Earnings Call Transcript

May 07, 2026 / 08:30PM GMT
Release Date Price: $22.42 (-1.41%)
Operator

Good afternoon and welcome to 10X Genomics First Quarter 2026 Earnings Conference Call.

All participants are in a listen-only mode.

After the speaker's remarks, we will conduct a question-and-answer session.

To ask a question at this time, you'll need to press star followed by the number 1 on your telephone keypad.

As a reminder, this conference call is being recorded.

I would now like to turn the call over to Cassie Corneau, Senior Director, Investor Relations and Strategic Finance.

Thank you. Please go ahead.

Cassie Corneau
10X Genomics Inc - Senior Director & Investor Relations & Strategic Finance

Thank you, and good afternoon, everyone.

Earlier today, 10X Genomics released financial results for the first quarter ended March 31, 2026.

If you have not received this news release or would like to be added to the company's distribution list, please send an e-mail to [email protected].

An archived webcast of this call will be available on the Investor tab of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot